New Silkroutes Group Ltd
SGX:BMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
New Silkroutes Group Ltd
Cost of Revenue
New Silkroutes Group Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
New Silkroutes Group Ltd
SGX:BMT
|
Cost of Revenue
-$3.9m
|
CAGR 3-Years
49%
|
CAGR 5-Years
62%
|
CAGR 10-Years
22%
|
|
New Silkroutes Group Ltd
Glance View
New Silkroutes Group Ltd. operates as an investment holding company, which engages in healthcare sector. The firm operates in the healthcare sector. The Company’s healthcare division focused on the provision of healthcare and related services, and operates through its subsidiary, Healthsciences International Pte. Ltd. (HSI). HSI owns and operates primary care medical and dental clinics in Singapore. The firm has also extended its healthcare portfolio into healthcare-related supplies through its subsidiary, Shanghai Fengwei Garment Accessory Co., Ltd (Shanghai Fengwei) in China. Shanghai Fengwei produces the non-woven material, which is used to manufacture disposable medical consumables, such as hospital gowns and linen, personal protective equipment and masks. The company owns approximately 16 clinics comprising one dental specialist clinic, eight dental clinics, five family medicine clinics, one aesthetic clinic and one traditional Chinese medicine (TCM) clinic, as well as one dental supplies company.
See Also
What is New Silkroutes Group Ltd's Cost of Revenue?
Cost of Revenue
-3.9m
USD
Based on the financial report for Sep 30, 2024, New Silkroutes Group Ltd's Cost of Revenue amounts to -3.9m USD.
What is New Silkroutes Group Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
22%
Over the last year, the Cost of Revenue growth was 69%. The average annual Cost of Revenue growth rates for New Silkroutes Group Ltd have been 49% over the past three years , 62% over the past five years , and 22% over the past ten years .
